Literature DB >> 26676416

Hereditary gastrointestinal cancer.

Keisuke Hata1, Yoko Yamamoto1, Tomomichi Kiyomatsu1, Toshiaki Tanaka1, Shinsuke Kazama1, Hiroaki Nozawa1, Kazushige Kawai1, Junichiro Tanaka1, Takeshi Nishikawa1, Kensuke Otani1, Koji Yasuda1, Junko Kishikawa1, Yuzo Nagai1, Hiroyuki Anzai1, Takahide Shinagawa1, Keiichi Arakawa1, Hironori Yamaguchi1, Soichiro Ishihara1, Eiji Sunami1, Joji Kitayama1, Toshiaki Watanabe2.   

Abstract

Gastrointestinal (GI) cancer, including gastric and colorectal cancer, is a major cause of death worldwide. A substantial proportion of patients with GI cancer have a familial history, and several causative genes have been identified. Gene carriers with these hereditary GI syndromes often harbor several kinds of cancer at an early age, and genetic testing and specific surveillance may save their lives through early detection. Gastroenterologists and GI surgeons should be familiar with these syndromes, even though they are not always associated with a high penetrance of GI cancer. In this review, we provide an overview and discuss the diagnosis, genetic testing, and management of four major hereditary GI cancers: familial adenomatous polyposis, Lynch syndrome, hereditary diffuse gastric cancer, and Li-Fraumeni syndrome.

Entities:  

Keywords:  Familial adenomatous polyposis; Hereditary diffuse gastric cancer; Li–Fraumeni syndrome; Lynch syndrome

Mesh:

Substances:

Year:  2015        PMID: 26676416     DOI: 10.1007/s00595-015-1283-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  62 in total

1.  Familial gastric cancer: update for practice management.

Authors:  Giovanni Corso; Daniele Marrelli; Franco Roviello
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 2.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 3.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.

Authors:  M H Nieuwenhuis; H F A Vasen
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-24       Impact factor: 6.312

4.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Authors:  Anita Villani; Uri Tabori; Joshua Schiffman; Adam Shlien; Joseph Beyene; Harriet Druker; Ana Novokmet; Jonathan Finlay; David Malkin
Journal:  Lancet Oncol       Date:  2011-05-19       Impact factor: 41.316

5.  Absence of microsatellite instability and germline mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer.

Authors:  M Kusano; H Kakiuchi; M Mihara; F Itoh; Y Adachi; M Ohara; M Hosokawa; K Imai
Journal:  Tumour Biol       Date:  2001 Jul-Aug

6.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

Review 7.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  Usefulness of prophylactic gastrectomy in a novel large hereditary diffuse gastric cancer (HDGC) family.

Authors:  Olivier Caron; Astrid Schielke; Magali Svrcek; Jean-François Fléjou; Jacob Garzon; Sylviane Olschwang; Alain Sézeur
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

9.  The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.

Authors:  T Iwama; Y Mishima; J Utsunomiya
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

10.  Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized.

Authors:  Takaharu Kato; Koichi Suzuki; Yuta Muto; Junichi Sasaki; Shingo Tsujinaka; Yutaka J Kawamura; Hiroshi Noda; Hisanaga Horie; Fumio Konishi; Toshiki Rikiyama
Journal:  World J Surg Oncol       Date:  2015-02-07       Impact factor: 2.754

View more
  7 in total

1.  The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.

Authors:  Ryuma Tokunaga; Yasuo Sakamoto; Shigeki Nakagawa; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2017-01-06       Impact factor: 2.549

2.  Current status of prophylactic surgical treatment for familial adenomatous polyposis in Japan.

Authors:  Masato Yamadera; Hideki Ueno; Hirotoshi Kobayashi; Tsuyoshi Konishi; Fumio Ishida; Tatsuro Yamaguchi; Takao Hinoi; Yasuhiro Inoue; Yukihide Kanemitsu; Naohiro Tomita; Hideyuki Ishida; Kenichi Sugihara
Journal:  Surg Today       Date:  2016-10-21       Impact factor: 2.549

3.  The treatment of desmoid tumors associated with familial adenomatous polyposis: the results of a Japanese multicenter observational study.

Authors:  Yasuhiro Inoue; Hideyuki Ishida; Hideki Ueno; Hirotoshi Kobayashi; Tatsuro Yamaguchi; Tsuyoshi Konishi; Naohiro Tomita; Nagahide Matsubara; Fumio Ishida; Takao Hinoi; Yukihide Kanemitsu; Toshiaki Watanabe; Kenichi Sugihara
Journal:  Surg Today       Date:  2017-03-01       Impact factor: 2.549

4.  How does inflammation drive mutagenesis in colorectal cancer?

Authors:  Chia Wei Hsu; Mark L Sowers; Willie Hsu; Eduardo Eyzaguirre; Suimin Qiu; Celia Chao; Charles P Mouton; Yuri Fofanov; Pomila Singh; Lawrence C Sowers
Journal:  Trends Cancer Res       Date:  2017

5.  Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.

Authors:  Keiichi Arakawa; Keisuke Hata; Yoko Yamamoto; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Hiroaki Nozawa; Masafumi Yoshida; Hiroshi Fukuhara; Mitsuhiro Fujishiro; Teppei Morikawa; Tatsuya Yamasoba; Kazuhiko Koike; Masashi Fukayama; Toshiaki Watanabe
Journal:  BMC Cancer       Date:  2018-01-04       Impact factor: 4.430

Review 6.  Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.

Authors:  Shamshul Ansari; Boldbaatar Gantuya; Vo Phuoc Tuan; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

7.  Role of video capsule endoscopy in patients with constitutional mismatch repair deficiency (CMMRD) syndrome: report from the International CMMRD Consortium.

Authors:  Y Shimamura; C M Walsh; S Cohen; M Aronson; U Tabori; P P Kortan; C A Durno
Journal:  Endosc Int Open       Date:  2018-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.